Current and new generation pneumococcal vaccines
C Feldman, R Anderson - Journal of Infection, 2014 - Elsevier
Pneumococcal polysaccharide vaccines (PPVs) and conjugate vaccines (PCVs), of which
PPV23 and PCV13 are the current front runners, have had a significant, beneficial impact on …
PPV23 and PCV13 are the current front runners, have had a significant, beneficial impact on …
Understanding the burden of pneumococcal disease in adults
F Blasi, M Mantero, PA Santus… - Clinical Microbiology and …, 2012 - Wiley Online Library
Clin Microbiol Infect 2012; 18 (Suppl. 5): 7–14 Abstract Streptococcus pneumoniae causes
different types of acute, invasive and non‐invasive clinical infections, being the most …
different types of acute, invasive and non‐invasive clinical infections, being the most …
[HTML][HTML] Pneumococcal vaccine for adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023
M Kobayashi - MMWR. Recommendations and Reports, 2023 - cdc.gov
This report compiles and summarizes all published recommendations from CDC's Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …
The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study
RAC Siemieniuk, DB Gregson, MJ Gill - BMC infectious diseases, 2011 - Springer
Background The increasing use of highly active antiretroviral therapy (HAART) and
pneumococcal immunization along with shifting community exposures may have altered the …
pneumococcal immunization along with shifting community exposures may have altered the …
Bloodstream infections in HIV-infected patients
L Taramasso, P Tatarelli, A Di Biagio - Virulence, 2016 - Taylor & Francis
In the combined antiretroviral therapy era, HIV-infected patients remain a vulnerable
population for the onset of bloodstream infections (BSI). Worldwide, nontyphoid …
population for the onset of bloodstream infections (BSI). Worldwide, nontyphoid …
Invasive pneumococcal disease among HIV-positive individuals, 2000–2009
Objectives: To examine invasive pneumococcal disease (IPD) incidence, the impact of the 7-
valent pneumococcal conjugate vaccines (PCV7s) programme on the distribution of …
valent pneumococcal conjugate vaccines (PCV7s) programme on the distribution of …
Immunogenicity of pneumococcal vaccination in HIV infected individuals: a systematic review and meta-analysis
HMG Garrido, JL Schnyder, MWT Tanck… - …, 2020 - thelancet.com
Background The objective of this systematic review and meta-analysis was to summarise the
literature regarding the immunogenicity of pneumococcal conjugate vaccines (PCV) and …
literature regarding the immunogenicity of pneumococcal conjugate vaccines (PCV) and …
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults previously vaccinated with pneumococcal polysaccharide vaccine
Background. Persons with human immunodeficiency virus (HIV) infection are at increased
risk of pneumococcal disease. We evaluated the safety and immunogenicity of 13-valent …
risk of pneumococcal disease. We evaluated the safety and immunogenicity of 13-valent …
Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals
MC Nunes, SA Madhi - Human vaccines & immunotherapeutics, 2012 - Taylor & Francis
Streptococcus pneumoniae is the leading bacterial opportunistic infection in HIV-infected
individuals. Anti-retroviral treatment (ART) of HIV-infected individuals reduces their risk of …
individuals. Anti-retroviral treatment (ART) of HIV-infected individuals reduces their risk of …
Vaccinations for the HIV-infected adult: a review of the current recommendations, part I
NF Crum-Cianflone, E Sullivan - Infectious Diseases and Therapy, 2017 - Springer
Vaccination is a critical component for ensuring the health of those living with the human
immunodeficiency virus (HIV) by protection against vaccine-preventable diseases. Since …
immunodeficiency virus (HIV) by protection against vaccine-preventable diseases. Since …